Researchers from Eindhoven University of Technology (TU/e) and Keio University today present a practicable and reliable way to test for infectious diseases.
All you need are a special glowing paper strip, a drop of blood and a digital camera, as they write in the scientific journal Angewandte Chemie. Not only does this make the technology very cheap and fast – after twenty minutes it is clear whether there is an infection – it also makes expensive and time-consuming laboratory measurements in the hospital unnecessary. In addition, the test has a lot of potential in developing countries for the easy testing of tropical diseases.
The test shows the presence of infectious diseases by searching for certain antibodies in the blood that your body makes in response to, for example, viruses and bacteria. The development of handy tests for the detection of antibodies is in the spotlight as a practicable and quick alternative to expensive, time-consuming laboratory measurements in hospitals. Doctors are also increasingly using antibodies as medicines, for example in the case of cancer or rheumatism. So this simple test is also suitable for regularly monitoring the dose of such medicines to be able to take corrective measures in good time.
The use of the paper strip developed by the Dutch and Japanese researchers is a piece of cake. Apply a drop of blood to the appropriate place on the paper, wait twenty minutes and turn it over. “A biochemical reaction causes the underside of paper to emit blue-green light,” says Eindhoven University of Technology professor and research leader Maarten Merkx. “The bluer the color, the higher the concentration of antibodies.” A digital camera, for example from a mobile phone, is sufficient to determine the exact color and thus the result.
The color is created thanks to the secret ingredient of the paper strip: a so-called luminous sensor protein developed at TU/e. After a droplet of blood comes onto the paper, this protein triggers a reaction in which blue light is produced (known as bioluminescence). An enzyme that also illuminates fireflies and certain fish, for example, plays a role in this. In a second step, the blue light is converted into green light. But here comes the clue: if an antibody binds to the sensor protein, it blocks the second step. A lot of green means few antibodies and, vice versa, less green means more antibodies.
The ratio of blue and green light can be used to derive the concentration of antibodies. “So not only do you know whether the antibody is in the blood, but also how much,” says Merkx. By measuring the ratio precisely, they suffer less from problems that other biosensors often have, such as the signal becoming weaker over time. In their prototype, they successfully tested three antibodies simultaneously, for HIV, flu and dengue fever. Merkx expects the test to be commercially available within a few years.
The Latest on: Test for infectious diseases
via Google News
The Latest on: Test for infectious diseases
- Infectious diseases beds 47% full in N Kazakhstanon August 23, 2021 at 1:15 am
PETROPAVLOVSK. KAZIFORM – North Kazakhstan region has logged 159 fresh COVID-19 cases in the past 24 hours, Kazinform correspondent reports.
- New Lab Studies Suggest InBios COVID-19 POC Antigen Detection Test Will Detect Delta Varianton August 22, 2021 at 6:00 am
SCoV-2 Ag Detect Rapid Test is Easily Performed in a Variety of Settings with Fast Results SEATTLE (PRWEB) August 22, 2021 InBios International Inc., a leading developer ...
- Time-Restricted Eating Has Important Health Benefits – Even With Infectious Diseases Such As COVID-19on August 21, 2021 at 12:32 am
Not everyone benefits equally from time-restricted eating, as health benefits depend on age and sex. Time-restricted eating (TRE), a dietary regimen that restricts eating to specific hours, has ...
- Jacksonville doctor explains why at-home COVID tests workon August 20, 2021 at 3:03 pm
Dr. Mohammed Reza, infectious disease physician says there was a study performed in March that looked at 64 antigen tests to evaluate their efficacy.
- Ready-to-use Laboratory Test Kits Market Pegged for Robust Expansion by 2030on August 19, 2021 at 8:11 pm
Snapshot. Ready-to-use laboratory test kits are gaining popularity owing to gamut of advantages they offer. These test kits help i ...
- The Infectious Diseases Diagnostics Market To Reach A Decisive US$ 1503.8 Million Between 2024on August 18, 2021 at 1:56 pm
The Infectious Diseases Diagnostics Market Share is expected to witness a CAGR of 7.9% between 2024 (reaching US$ 1503.8 Million). Vertical integration is the latest trend concerning the healthcare ...
- Infectious Disease POC Diagnostics Market Size | Is Expected to Reach USD 3.96 Billion by 2028 while Exhibiting an Impressive CAGR of 17.2%on August 17, 2021 at 11:41 pm
Key Prominent Players Covered in the Infectious Disease Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland) , Thermo Fisher Scientific Inc.
- Karius receives New York State permit for its liquid biopsy test to detect infectious diseaseson August 17, 2021 at 5:13 am
Karius, the world leader in liquid biopsy for infectious diseases, has received approval from the New York State Department of Health's Clinical Laboratory Evaluation Program (CLEP) for its Karius ...
- Infectious Disease Diagnostics Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2027on August 16, 2021 at 7:16 am
CAGR of 6.0%, Market Trends – The rising demand for Infectious Disease Diagnostics amidst coronavirus pandemic The Global Infectious Disease Diagnostics market is forecast to reach USD 28.03 Billion ...
via Bing News